Pacific Biosciences of Ca... (PACB)
NASDAQ: PACB
· Real-Time Price · USD
1.23
-0.05 (-3.91%)
At close: Aug 14, 2025, 3:59 PM
1.24
0.79%
After-hours: Aug 14, 2025, 07:41 PM EDT
-3.91% (1D)
| Bid | 1.23 |
| Market Cap | 369.46M |
| Revenue (ttm) | 152.36M |
| Net Income (ttm) | -657.75M |
| EPS (ttm) | -2.23 |
| PE Ratio (ttm) | -0.55 |
| Forward PE | -2.57 |
| Analyst | Hold |
| Ask | 1.3 |
| Volume | 13,387,997 |
| Avg. Volume (20D) | 9,471,877 |
| Open | 1.32 |
| Previous Close | 1.28 |
| Day's Range | 1.22 - 1.35 |
| 52-Week Range | 0.85 - 2.72 |
| Beta | 2.17 |
About PACB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PACB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PACB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Pacific Biosciences of California has released their quartely earnings
on Aug 7, 2025:
Next Earnings Release
Pacific Biosciences of California Inc. is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+7.14%
Pacific Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
1 week ago
-8.7%
PACB stock has given up its prior gain. Pacific Biosciences shares were trading higher after the company reported better-than-expected Q2 financial results.
1 week ago · seekingalpha.com
Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call TranscriptPacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.
1 week ago · fool.com
PACB Sales Up 11%PACB Sales Up 11%
